Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Melanoma

Free Subscription Articles published in Clin Cancer Res Retrieve available abstracts of 116 articles: HTML format

Single Articles

April 2008
1. SALEEM M , Maddodi N, Abu Zaid M, Khan N, et al
   Lupeol Inhibits Growth of Highly Aggressive Human Metastatic Melanoma Cells In vitro and In vivo by Inducing Apoptosis.
   Clin Cancer Res. 2008;14:2119-27.
   PubMed     Related articles    Abstract available
   
   
   February 2008
2. AVERY-KIEJDA KA , Zhang XD, Adams LJ, Scott RJ, et al
   Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin.
   Clin Cancer Res. 2008;.
   PubMed     Related articles    Abstract available   Free Full Text
   
   
   
3. BAKALIAN S , Marshall JC, Logan P, Faingold D, et al
   Molecular pathways mediating liver metastasis in patients with uveal melanoma.
   Clin Cancer Res. 2008;14:951-6.
   PubMed     Related articles    Abstract available
   
   
   
4. DUMMER R , Hauschild A, Becker JC, Grob JJ, et al
   An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma.
   Clin Cancer Res. 2008;14:856-64.
   PubMed     Related articles    Abstract available
   
   
   
5. FAINGOLD D , Marshall JC, Antecka E, Di Cesare S, et al
   Immune Expression and Inhibition of Heat Shock Protein 90 in Uveal Melanoma.
   Clin Cancer Res. 2008;14:847-855.
   PubMed     Related articles    Abstract available
   
   
   
6. NEGIN B , Panka D, Wang W, Siddiqui M, et al
   Effect of melanoma on immune function in the regional lymph node basin.
   Clin Cancer Res. 2008;14:654-9.
   PubMed     Related articles    Abstract available
   
   
   
7. AMERSI FF , Terando AM, Goto Y, Scolyer RA, et al
   Activation of CCR9/CCL25 in Cutaneous Melanoma Mediates Preferential Metastasis to the Small Intestine.
   Clin Cancer Res. 2008;14:638-45.
   PubMed     Related articles    Abstract available
   
   
   
8. RICHMOND A
   CCR9 Homes Metastatic Melanoma Cells to the Small Bowel.
   Clin Cancer Res. 2008;14:621-3.
   PubMed     Related articles   
   
   
   January 2008
9. HAASS NK , Sproesser K, Nguyen TK, Contractor R, et al
   The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel.
   Clin Cancer Res. 2008;14:230-9.
   PubMed     Related articles    Abstract available
   
   
   
10. EHLERS JP , Worley L, Onken MD, Harbour JW, et al
    Integrative genomic analysis of aneuploidy in uveal melanoma.
    Clin Cancer Res. 2008;14:115-22.
    PubMed     Related articles    Abstract available
    
    
    
11. QIAO J , Wang H, Kottke T, White C, et al
    Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus.
    Clin Cancer Res. 2008;14:259-69.
    PubMed     Related articles    Abstract available
    
    
    December 2007
12. MACCALLI C , Nonaka D, Piris A, Pende D, et al
    NKG2D-Mediated Antitumor Activity by Tumor-Infiltrating Lymphocytes and Antigen-Specific T-Cell Clones Isolated from Melanoma Patients.
    Clin Cancer Res. 2007;13:7459-68.
    PubMed     Related articles    Abstract available
    
    
    
13. WANG E , Selleri S, Marincola FM
    The Requirements for CTL-Mediated Rejection of Cancer in Humans: NKG2D and Its Role in the Immune Responsiveness of Melanoma.
    Clin Cancer Res. 2007;13:7228-31.
    PubMed     Related articles   
    
    
    
14. ZAMBONI WC , Strychor S, Joseph E, Walsh DR, et al
    Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma Xenografts.
    Clin Cancer Res. 2007;13:7217-7223.
    PubMed     Related articles    Abstract available
    
    
    November 2007
15. ABBAS S , Bhoumik A, Dahl R, Vasile S, et al
    Preclinical Studies of Celastrol and Acetyl Isogambogic Acid in Melanoma.
    Clin Cancer Res. 2007;13:6769-6778.
    PubMed     Related articles    Abstract available
    
    
    
16. DOWNEY SG , Klapper JA, Smith FO, Yang JC, et al
    Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade.
    Clin Cancer Res. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
17. SLINGLUFF CL JR , Petroni GR, Chianese-Bullock KA, Smolkin ME, et al
    Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting.
    Clin Cancer Res. 2007;13:6386-6395.
    PubMed     Related articles    Abstract available
    
    
    
18. UGUREL S , Houben R, Schrama D, Voigt H, et al
    Microphthalmia-Associated Transcription Factor Gene Amplification in Metastatic Melanoma Is a Prognostic Marker for Patient Survival, But Not a Predictive Marker for Chemosensitivity and Chemotherapy Response.
    Clin Cancer Res. 2007;13:6344-6350.
    PubMed     Related articles    Abstract available
    
    
    October 2007
19. COTTER MA , Thomas J, Cassidy P, Robinette K, et al
    N-Acetylcysteine Protects Melanocytes against Oxidative Stress/Damage and Delays Onset of Ultraviolet-Induced Melanoma in Mice.
    Clin Cancer Res. 2007;13:5952-8.
    PubMed     Related articles    Abstract available
    
    
    September 2007
20. GAJEWSKI TF
    Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment.
    Clin Cancer Res. 2007;13:5256-61.
    PubMed     Related articles    Abstract available
    
    
    
21. GOLLOB JA , Sciambi CJ
    Decitabine Up-regulates S100A2 Expression and Synergizes with IFN-{gamma} to Kill Uveal Melanoma Cells.
    Clin Cancer Res. 2007;13:5219-5225.
    PubMed     Related articles    Abstract available
    
    
    
22. LESINSKI GB , Trefry J, Brasdovich M, Kondadasula SV, et al
    Melanoma Cells Exhibit Variable Signal Transducer and Activator of Transcription 1 Phosphorylation and a Reduced Response to IFN-{alpha} Compared with Immune Effector Cells.
    Clin Cancer Res. 2007;13:5010-5019.
    PubMed     Related articles    Abstract available
    
    
    August 2007
23. CHAKRAVARTI N , Lotan R, Diwan AH, Warneke CL, et al
    Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis.
    Clin Cancer Res. 2007;13:4817-24.
    PubMed     Related articles    Abstract available
    
    
    
24. KONDO T , Zhu X, Asa SL, Ezzat S, et al
    The Cancer/Testis Antigen Melanoma-Associated Antigen-A3/A6 Is a Novel Target of Fibroblast Growth Factor Receptor 2-IIIb through Histone H3 Modifications in Thyroid Cancer.
    Clin Cancer Res. 2007;13:4713-20.
    PubMed     Related articles    Abstract available
    
    
    
25. SALAUN B , Lebecque S, Matikainen S, Rimoldi D, et al
    Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy?
    Clin Cancer Res. 2007;13:4565-74.
    PubMed     Related articles    Abstract available
    
    
    July 2007
26. WANG YF , Jiang CC, Kiejda KA, Gillespie S, et al
    Apoptosis Induction in Human Melanoma Cells by Inhibition of MEK Is Caspase-Independent and Mediated by the Bcl-2 Family Members PUMA, Bim, and Mcl-1.
    Clin Cancer Res. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
27. WANG Y , Dai DL, Martinka M, Li G, et al
    Prognostic Significance of Nuclear ING3 Expression in Human Cutaneous Melanoma.
    Clin Cancer Res. 2007;13:4111-6.
    PubMed     Related articles    Abstract available
    
    
    
28. ELLIOTT B , Scolyer RA, Suciu S, Lebecque S, et al
    Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma.
    Clin Cancer Res. 2007;13:3825-30.
    PubMed     Related articles    Abstract available
    
    
    June 2007
29. DAVIS ID , Skrumsager BK, Cebon J, Nicholaou T, et al
    An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma.
    Clin Cancer Res. 2007;13:3630-6.
    PubMed     Related articles    Abstract available
    
    
    
30. EWEND MG , Brem S, Gilbert M, Goodkin R, et al
    Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control.
    Clin Cancer Res. 2007;13:3637-41.
    PubMed     Related articles    Abstract available
    
    
    
31. FONSATTI E , Nicolay HJ, Sigalotti L, Calabro L, et al
    Functional Up-regulation of Human Leukocyte Antigen Class I Antigens Expression by 5-aza-2'-deoxycytidine in Cutaneous Melanoma: Immunotherapeutic Implications.
    Clin Cancer Res. 2007;13:3333-8.
    PubMed     Related articles    Abstract available
    
    
    
32. MARGOLIN K , Atkins MB, Dutcher JP, Ernstoff MS, et al
    Phase I Trial of BAY 50-4798, an Interleukin-2-Specific Agonist in Advanced Melanoma and Renal Cancer.
    Clin Cancer Res. 2007;13:3312-9.
    PubMed     Related articles    Abstract available
    
    
    
33. TORISU-ITAKURA H , Lee JH, Scheri RP, Huynh Y, et al
    Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma.
    Clin Cancer Res. 2007;13:3125-32.
    PubMed     Related articles    Abstract available
    
    
    May 2007
34. MOLENKAMP BG , van Leeuwen PA, Meijer S, Sluijter BJ, et al
    Intradermal CpG-B Activates Both Plasmacytoid and Myeloid Dendritic Cells in the Sentinel Lymph Node of Melanoma Patients.
    Clin Cancer Res. 2007;13:2961-9.
    PubMed     Related articles    Abstract available
    
    
    
35. ONKEN MD , Worley LA, Person E, Char DH, et al
    Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma.
    Clin Cancer Res. 2007;13:2923-7.
    PubMed     Related articles    Abstract available
    
    
    
36. AZUMA Y , Ishikawa Y, Kawai S, Tsunenari T, et al
    Recombinant Human Hexamer-Dominant IgM Monoclonal Antibody to Ganglioside GM3 for Treatment of Melanoma.
    Clin Cancer Res. 2007;13:2745-50.
    PubMed     Related articles    Abstract available
    
    
    
37. MENA S , Benlloch M, Ortega A, Carretero J, et al
    Bcl-2 and glutathione depletion sensitizes b16 melanoma to combination therapy and eliminates metastatic disease.
    Clin Cancer Res. 2007;13:2658-66.
    PubMed     Related articles    Abstract available
    
    
    
38. WEISHAUPT C , Munoz KN, Buzney E, Kupper TS, et al
    T-cell distribution and adhesion receptor expression in metastatic melanoma.
    Clin Cancer Res. 2007;13:2549-56.
    PubMed     Related articles    Abstract available
    
    
    April 2007
39. YURKOVETSKY ZR , Kirkwood JM, Edington HD, Marrangoni AM, et al
    Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-{alpha}2b.
    Clin Cancer Res. 2007;13:2422-8.
    PubMed     Related articles    Abstract available
    
    
    
40. PURI N , Ahmed S, Janamanchi V, Tretiakova M, et al
    c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma.
    Clin Cancer Res. 2007;13:2246-53.
    PubMed     Related articles    Abstract available
    
    
    
41. VAN DERVLIET HJ , Koon HB, Yue SC, Uzunparmak B, et al
    Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.
    Clin Cancer Res. 2007;13:2100-8.
    PubMed     Related articles    Abstract available
    
    
    
42. SHINOZAKI M , O'day SJ, Kitago M, Amersi F, et al
    Utility of Circulating B-RAF DNA Mutation in Serum for Monitoring Melanoma Patients Receiving Biochemotherapy.
    Clin Cancer Res. 2007;13:2068-74.
    PubMed     Related articles    Abstract available
    
    
    
43. GALLAGHER DC , Bhatt RS, Parikh SM, Patel P, et al
    Angiopoietin 2 is a potential mediator of high-dose interleukin 2-induced vascular leak.
    Clin Cancer Res. 2007;13:2115-20.
    PubMed     Related articles    Abstract available
    
    
    
44. ROFSTAD EK , Galappathi K, Mathiesen B, Ruud EB, et al
    Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis.
    Clin Cancer Res. 2007;13:1971-8.
    PubMed     Related articles    Abstract available
    
    
    March 2007
45. STELLAS D , Karameris A, Patsavoudi E
    Monoclonal Antibody 4C5 Immunostains Human Melanomas and Inhibits Melanoma Cell Invasion and Metastasis.
    Clin Cancer Res. 2007;13:1831-8.
    PubMed     Related articles    Abstract available
    
    
    
46. ESCUDIER B , Lassau N, Angevin E, Soria JC, et al
    Phase I Trial of Sorafenib in Combination with IFN {alpha}-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma.
    Clin Cancer Res. 2007;13:1801-9.
    PubMed     Related articles    Abstract available
    
    
    
47. BUTLER MO , Lee JS, Ansen S, Neuberg D, et al
    Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.
    Clin Cancer Res. 2007;13:1857-67.
    PubMed     Related articles    Abstract available
    
    
    
48. PALMIERI D , Chambers AF, Felding-Habermann B, Huang S, et al
    The biology of metastasis to a sanctuary site.
    Clin Cancer Res. 2007;13:1656-62.
    PubMed     Related articles    Abstract available
    
    
    
49. WANG W , Edington HD, Rao UN, Jukic DM, et al
    Modulation of Signal Transducers and Activators of Transcription 1 and 3 Signaling in Melanoma by High-Dose IFN{alpha}2b.
    Clin Cancer Res. 2007;13:1523-31.
    PubMed     Related articles    Abstract available
    
    
    
50. WORLEY LA , Onken MD, Person E, Robirds D, et al
    Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma.
    Clin Cancer Res. 2007;13:1466-71.
    PubMed     Related articles    Abstract available
    
    
    February 2007
51. MHAIDAT NM , Zhang XD, Jiang CC, Hersey P, et al
    Docetaxel-Induced Apoptosis of Human Melanoma Is Mediated by Activation of c-Jun NH2-Terminal Kinase and Inhibited by the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway.
    Clin Cancer Res. 2007;13:1308-14.
    PubMed     Related articles    Abstract available
    
    
    
52. SCHUSTER R , Bechrakis NE, Stroux A, Busse A, et al
    Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Clin Cancer Res. 2007;13:1171-8.
    PubMed     Related articles    Abstract available
    
    
    
53. JAEGER J , Koczan D, Thiesen HJ, Ibrahim SM, et al
    Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.
    Clin Cancer Res. 2007;13:806-15.
    PubMed     Related articles    Abstract available
    
    
    January 2007
54. CASSADAY RD , Sondel PM, King DM, Macklin MD, et al
    A Phase I Study of Immunization Using Particle-Mediated Epidermal Delivery of Genes for gp100 and GM-CSF into Uninvolved Skin of Melanoma Patients.
    Clin Cancer Res. 2007;13:540-9.
    PubMed     Related articles    Abstract available
    
    
    
55. HAMID O , Solomon JC, Scotland R, Garcia M, et al
    Alum with interleukin-12 augments immunity to a melanoma Peptide vaccine: correlation with time to relapse in patients with resected high-risk disease.
    Clin Cancer Res. 2007;13:215-22.
    PubMed     Related articles    Abstract available
    
    
    December 2006
56. ABI-HABIB RJ , Singh R, Leppla SH, Greene JJ, et al
    Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice.
    Clin Cancer Res. 2006;12:7437-43.
    PubMed     Related articles    Abstract available
    
    
    
57. LESIMPLE T , Neidhard EM, Vignard V, Lefeuvre C, et al
    Immunologic and clinical effects of injecting mature Peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.
    Clin Cancer Res. 2006;12:7380-8.
    PubMed     Related articles    Abstract available
    
    
    
58. ASEMISSEN AM , Keilholz U, Tenzer S, Muller M, et al
    Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1.
    Clin Cancer Res. 2006;12:7476-82.
    PubMed     Related articles    Abstract available
    
    
    
59. CESSON V , Stirnemann K, Robert B, Luescher I, et al
    Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Clin Cancer Res. 2006;12:7422-30.
    PubMed     Related articles    Abstract available
    
    
    
60. GABRI MR , Mazorra Z, Ripoll GV, Mesa C, et al
    Complete Antitumor Protection by Perioperative Immunization with GM3/VSSP Vaccine in a Preclinical Mouse Melanoma Model.
    Clin Cancer Res. 2006;12:7092-8.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
61. ZYKOVA TA , Zhu F, Lu C, Higgins L, et al
    Lymphokine-Activated Killer T-Cell-Originated Protein Kinase Phosphorylation of Histone H2AX Prevents Arsenite-Induced Apoptosis in RPMI7951 Melanoma Cells.
    Clin Cancer Res. 2006;12:6884-93.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    November 2006
62. PRIETO VG , Mourad-Zeidan AA, Melnikova V, Johnson MM, et al
    Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
    Clin Cancer Res. 2006;12:6709-15.
    PubMed     Related articles    Abstract available
    
    
    
63. LI B , Lalani AS, Harding TC, Luan B, et al
    Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Clin Cancer Res. 2006;12:6808-16.
    PubMed     Related articles    Abstract available
    
    
    
64. HU JC , Coffin RS, Davis CJ, Graham NJ, et al
    A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor.
    Clin Cancer Res. 2006;12:6737-47.
    PubMed     Related articles    Abstract available
    
    
    October 2006
65. LEE YS , Kim JH, Choi KJ, Choi IK, et al
    Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Clin Cancer Res. 2006;12:5859-68.
    PubMed     Related articles    Abstract available
    
    
    
66. VARKER KA , Kondadasula SV, Go MR, Lesinski GB, et al
    Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Clin Cancer Res. 2006;12:5850-8.
    PubMed     Related articles    Abstract available
    
    
    
67. ISHIZAKI H , Tsunoda T, Wada S, Yamauchi M, et al
    Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1.
    Clin Cancer Res. 2006;12:5841-9.
    PubMed     Related articles    Abstract available
    
    
    
68. CHEN XY , Zhang W, Zhang W, Wu S, et al
    Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
    Clin Cancer Res. 2006;12:5834-40.
    PubMed     Related articles    Abstract available
    
    
    
69. GROVER A , Kim GJ, Lizee G, Tschoi M, et al
    Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.
    Clin Cancer Res. 2006;12:5801-8.
    PubMed     Related articles    Abstract available
    
    
    September 2006
70. UGUREL S , Schadendorf D, Pfohler C, Neuber K, et al
    In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.
    Clin Cancer Res. 2006;12:5454-63.
    PubMed     Related articles    Abstract available
    
    
    
71. BASCHE M , Gustafson DL, Holden SN, O'Bryant CL, et al
    A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors.
    Clin Cancer Res. 2006;12:5471-80.
    PubMed     Related articles    Abstract available
    
    
    August 2006
72. BENIMETSKAYA L , Ayyanar K, Kornblum N, Castanotto D, et al
    Bcl-2 Protein in 518A2 Melanoma Cells In vivo and In vitro.
    Clin Cancer Res. 2006;12:4940-8.
    PubMed     Related articles    Abstract available
    
    
    
73. CAMPILLO JA , Martinez-Escribano JA, Moya-Quiles MR, Marin LA, et al
    Natural Killer Receptors on CD8 T Cells and Natural Killer Cells from Different HLA-C Phenotypes in Melanoma Patients.
    Clin Cancer Res. 2006;12:4822-31.
    PubMed     Related articles    Abstract available
    
    
    
74. GOLLOB JA , Sciambi CJ, Peterson BL, Richmond T, et al
    Phase I Trial of Sequential Low-Dose 5-Aza-2'-Deoxycytidine Plus High-Dose Intravenous Bolus Interleukin-2 in Patients with Melanoma or Renal Cell Carcinoma.
    Clin Cancer Res. 2006;12:4619-4627.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
75. MOCELLIN S , Hoon D, Ambrosi A, Nitti D, et al
    The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis.
    Clin Cancer Res. 2006;12:4605-13.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
76. SALDANHA G , Potter L, Daforno P, Pringle JH, et al
    Cutaneous Melanoma Subtypes Show Different BRAF and NRAS Mutation Frequencies.
    Clin Cancer Res. 2006;12:4499-505.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    July 2006
77. ROBERTSON MJ , Mier JW, Logan T, Atkins M, et al
    Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer.
    Clin Cancer Res. 2006;12.
    PubMed     Related articles    Abstract available
    
    
    
78. AMARZGUIOUI M , Peng Q, Wiiger MT, Vasovic V, et al
    Ex vivo and In vivo Delivery of Anti-Tissue Factor Short Interfering RNA Inhibits Mouse Pulmonary Metastasis of B16 Melanoma Cells.
    Clin Cancer Res. 2006;12:4055-61.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    June 2006
79. MCCARTHY MM , Divito KA, Sznol M, Kovacs D, et al
    Expression of tumor necrosis factor-related apoptosis-inducing ligand receptors 1 and 2 in melanoma.
    Clin Cancer Res. 2006;12:3856-63.
    PubMed     Related articles    Abstract available
    
    
    
80. PASCHEN A , Arens N, Sucker A, Greulich-Bode KM, et al
    The Coincidence of Chromosome 15 Aberrations and {beta}2-Microglobulin Gene Mutations Is Causative for the Total Loss of Human Leukocyte Antigen Class I Expression in Melanoma.
    Clin Cancer Res. 2006;12:3297-305.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    May 2006
81. HELLER L , Merkler K, Westover J, Cruz Y, et al
    Evaluation of Toxicity following Electrically Mediated Interleukin-12 Gene Delivery in a B16 Mouse Melanoma Model.
    Clin Cancer Res. 2006;12:3177-83.
    PubMed     Related articles    Abstract available
    
    
    
82. GRABACKA M , Plonka PM, Urbanska K, Reiss K, et al
    Peroxisome Proliferator-Activated Receptor {alpha} Activation Decreases Metastatic Potential of Melanoma Cells In vitro via Down-Regulation of Akt.
    Clin Cancer Res. 2006;12:3028-36.
    PubMed     Related articles    Abstract available
    
    
    
83. BRACK SS , Silacci M, Birchler M, Neri D, et al
    Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C.
    Clin Cancer Res. 2006;12:3200-8.
    PubMed     Related articles    Abstract available
    
    
    
84. GRIFFIOEN M , Kessler JH, Borghi M, van Soest RA, et al
    Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy.
    Clin Cancer Res. 2006;12:3130-6.
    PubMed     Related articles    Abstract available
    
    
    
85. REDDY PS , Ganesh S, Yu DC
    Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses.
    Clin Cancer Res. 2006;12:2869-78.
    PubMed     Related articles    Abstract available
    
    
    
86. VUYLSTEKE RJ , Molenkamp BG, van Leeuwen PA, Meijer S, et al
    Tumor-Specific CD8+ T Cell Reactivity in the Sentinel Lymph Node of GM-CSF-Treated Stage I Melanoma Patients is Associated with High Myeloid Dendritic Cell Content.
    Clin Cancer Res. 2006;12:2826-33.
    PubMed     Related articles    Abstract available
    
    
    
87. BROWN JR , Fuster MM, Li R, Varki N, et al
    A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination.
    Clin Cancer Res. 2006;12:2894-901.
    PubMed     Related articles    Abstract available
    
    
    
88. MATHIS JM , Stewart PL, Zhu ZB, Curiel DT, et al
    Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism.
    Clin Cancer Res. 2006;12:2651-6.
    PubMed     Related articles   
    
    
    April 2006
89. LINDSEY KR , Gritz L, Sherry R, Abati A, et al
    Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.
    Clin Cancer Res. 2006;12:2526-37.
    PubMed     Related articles    Abstract available
    
    
    
90. SCALA S , Giuliano P, Ascierto PA, Ierano C, et al
    Human melanoma metastases express functional CXCR4.
    Clin Cancer Res. 2006;12:2427-33.
    PubMed     Related articles    Abstract available
    
    
    
91. ROMEO MJ , Wunderlich J, Ngo L, Rosenberg SA, et al
    Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray.
    Clin Cancer Res. 2006;12:2463-7.
    PubMed     Related articles    Abstract available
    
    
    
92. SOSMAN JA , Puzanov I
    Molecular targets in melanoma from angiogenesis to apoptosis.
    Clin Cancer Res. 2006;12:2376s-83s.
    PubMed     Related articles    Abstract available
    
    
    
93. PANKA DJ , Atkins MB, Mier JW
    Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma.
    Clin Cancer Res. 2006;12:2371s-5s.
    PubMed     Related articles    Abstract available
    
    
    
94. FLAHERTY KT
    Chemotherapy and targeted therapy combinations in advanced melanoma.
    Clin Cancer Res. 2006;12:2366s-70s.
    PubMed     Related articles    Abstract available
    
    
    
95. LIZEE G , Radvanyi LG, Overwijk WW, Hwu P, et al
    Immunosuppression in melanoma immunotherapy: potential opportunities for intervention.
    Clin Cancer Res. 2006;12:2359s-65s.
    PubMed     Related articles    Abstract available
    
    
    
96. ATKINS MB
    Cytokine-based therapy and biochemotherapy for advanced melanoma.
    Clin Cancer Res. 2006;12:2353s-8s.
    PubMed     Related articles    Abstract available
    
    
    
97. SONDAK VK , Sabel MS, Mule JJ
    Allogeneic and Autologous Melanoma Vaccines: Where Have We Been and Where Are We Going?
    Clin Cancer Res. 2006;12:2337s-2341s.
    PubMed     Related articles    Abstract available
    
    
    
98. KIRKWOOD JM , Moschos S, Wang W
    Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations.
    Clin Cancer Res. 2006;12:2331s-6s.
    PubMed     Related articles    Abstract available
    
    
    
99. GAJEWSKI TF
    Identifying and overcoming immune resistance mechanisms in the melanoma tumor microenvironment.
    Clin Cancer Res. 2006;12:2326s-30s.
    PubMed     Related articles    Abstract available
    
    
    
100. ESSNER R
     Sentinel lymph node biopsy and melanoma biology.
     Clin Cancer Res. 2006;12:2320s-5s.
     PubMed     Related articles    Abstract available
     
     
     
101. ROSS MI
     Early-stage melanoma: staging criteria and prognostic modeling.
     Clin Cancer Res. 2006;12:2312s-9s.
     PubMed     Related articles    Abstract available
     
     
     
102. ELDER DE
     Pathology of melanoma.
     Clin Cancer Res. 2006;12:2308s-11s.
     PubMed     Related articles    Abstract available
     
     
     
103. HALUSKA FG , Tsao H, Wu H, Haluska FS, et al
     Genetic alterations in signaling pathways in melanoma.
     Clin Cancer Res. 2006;12:2301s-7s.
     PubMed     Related articles    Abstract available
     
     
     
104. WEINSTOCK MA
     Progress and prospects on melanoma: the way forward for early detection and reduced mortality.
     Clin Cancer Res. 2006;12:2297s-300s.
     PubMed     Related articles    Abstract available
     
     
     
105. ATKINS MB , Elder DE, Essner R, Flaherty KT, et al
     Innovations and challenges in melanoma: summary statement from the first cambridge conference.
     Clin Cancer Res. 2006;12:2291s-6s.
     PubMed     Related articles    Abstract available
     
     
     
106. KUAN CT , Wakiya K, Dowell JM, Herndon JE 2nd, et al
     Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
     Clin Cancer Res. 2006;12:1970-82.
     PubMed     Related articles    Abstract available
     
     
     
107. 
     Innovation and challenges in melanoma. Proceedings of the first Cambridge conference. July 15-16, 2005. Cambridge, Massachusetts, USA.
     Clin Cancer Res. 2006;12.
     PubMed     Related articles   
     
     
     
108. KEILHOLZ U , Martus P, Scheibenbogen C
     Immune monitoring of T-cell responses in cancer vaccine development.
     Clin Cancer Res. 2006;12.
     PubMed     Related articles    Abstract available
     
     
     
109. SLINGLUFF CL JR , Engelhard VH, Ferrone S
     Peptide and dendritic cell vaccines.
     Clin Cancer Res. 2006;12.
     PubMed     Related articles    Abstract available
     
     
     
110. RICE JR , Gerberich JL, Nowotnik DP, Howell SB, et al
     Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
     Clin Cancer Res. 2006;12.
     PubMed     Related articles    Abstract available
     
     
     March 2006
111. OSENGA KL , Hank JA, Albertini MR, Gan J, et al
     A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Group.
     Clin Cancer Res. 2006;12:1750-9.
     PubMed     Related articles    Abstract available
     
     
     
112. LUO Y , Wen YJ, Ding ZY, Fu CH, et al
     Immunotherapy of tumors with protein vaccine based on chicken homologous Tie-2.
     Clin Cancer Res. 2006;12:1813-9.
     PubMed     Related articles    Abstract available
     
     
     February 2006
113. ERRINGTON F , Bateman A, Kottke T, Thompson J, et al
     Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.
     Clin Cancer Res. 2006;12:1333-41.
     PubMed     Related articles    Abstract available
     
     
     
114. ELARAJ DM , Weinreich DM, Varghese S, Puhlmann M, et al
     The role of interleukin 1 in growth and metastasis of human cancer xenografts.
     Clin Cancer Res. 2006;12:1088-96.
     PubMed     Related articles    Abstract available
     
     
     November 2005
115. EBBINGHAUS S , Rubin E, Hersh E, Cranmer LD, et al
     A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors.
     Clin Cancer Res. 2005;11:7807-16.
     PubMed     Related articles    Abstract available
     
     
     
116. FERRETTI S , Allegrini PR, O'Reilly T, Schnell C, et al
     Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure.
     Clin Cancer Res. 2005;11:7773-84.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: